Menu
GeneBe

17-7676041-G-C

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PM5

The NM_000546.6(TP53):c.328C>G(p.Arg110Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R110H) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)

Consequence

TP53
NM_000546.6 missense

Scores

3
8
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.507
Variant links:
Genes affected
TP53 (HGNC:11998): (tumor protein p53) This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM1
In a hotspot region, there are 9 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 4 benign, 16 uncertain in NM_000546.6
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr17-7676040-C-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 406597.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TP53NM_000546.6 linkuse as main transcriptc.328C>G p.Arg110Gly missense_variant 4/11 ENST00000269305.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TP53ENST00000269305.9 linkuse as main transcriptc.328C>G p.Arg110Gly missense_variant 4/111 NM_000546.6 P1P04637-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 09, 2019The p.R110G variant (also known as c.328C>G), located in coding exon 3 of the TP53 gene, results from a C to G substitution at nucleotide position 328. The arginine at codon 110 is replaced by glycine, an amino acid with dissimilar properties. This variant is in the DNA binding domain of the TP53 protein and is reported to have loss of transactivation in yeast based assays (IARC TP53 database: Kato S et al. Proc. Natl. Acad. Sci. USA 2003 Jul;100:8424-9). Studies conducted in human cell lines are equivocal about this variant's ability to suppress cell growth (Kotler E et al. Mol. Cell 2018 Jul;71:178-190.e8; Giacomelli AO et al. Nat. Genet. 2018 Oct;50:1381-1387). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Uncertain
0.060
Cadd
Benign
23
Dann
Uncertain
0.99
DEOGEN2
Uncertain
0.61
D;D;.;D;.;.;.;.;.;.;D;.;.;D;D;.
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.41
FATHMM_MKL
Benign
0.075
N
LIST_S2
Uncertain
0.96
D;D;.;.;.;D;D;.;D;D;D;D;T;D;D;D
M_CAP
Pathogenic
0.44
D
MetaRNN
Uncertain
0.55
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationTaster
Benign
1.0
N;N;N;N;N;N
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-2.2
N;N;.;D;.;.;N;N;.;.;D;.;.;D;.;D
REVEL
Uncertain
0.58
Sift
Uncertain
0.015
D;D;.;D;.;.;D;D;.;.;D;.;.;D;.;D
Sift4G
Uncertain
0.046
D;T;T;D;T;T;T;T;T;T;D;T;D;.;D;.
Polyphen
0.90
P;.;.;P;.;P;B;P;.;.;P;.;.;P;.;.
Vest4
0.49
MutPred
0.66
Loss of MoRF binding (P = 0.089);Loss of MoRF binding (P = 0.089);.;Loss of MoRF binding (P = 0.089);.;Loss of MoRF binding (P = 0.089);Loss of MoRF binding (P = 0.089);Loss of MoRF binding (P = 0.089);.;.;Loss of MoRF binding (P = 0.089);.;Loss of MoRF binding (P = 0.089);Loss of MoRF binding (P = 0.089);Loss of MoRF binding (P = 0.089);Loss of MoRF binding (P = 0.089);
MVP
0.96
MPC
1.8
ClinPred
0.71
D
GERP RS
0.048
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.44
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs587781371; hg19: chr17-7579359; COSMIC: COSV105873667; COSMIC: COSV105873667; API